BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36624066)

  • 1. Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA.
    Zhand S; Zhu Y; Nazari H; Sadraeian M; Warkiani ME; Jin D
    Anal Chem; 2023 Feb; 95(6):3228-3237. PubMed ID: 36624066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to "Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA".
    Zhand S; Zhu Y; Nazari H; Sadraeian M; Warkiani ME; Jin D
    Anal Chem; 2023 Aug; 95(32):12193. PubMed ID: 37534986
    [No Abstract]   [Full Text] [Related]  

  • 3. Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients.
    Wang J; Zhang H; Sun X; Wang X; Ren T; Huang Y; Zhang R; Zheng B; Guo W
    J Nanobiotechnology; 2020 Oct; 18(1):151. PubMed ID: 33092576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive Detection of Nucleic Acids Using Subzyme Feedback Cascades.
    Hasick N; Lawrence A; Ramadas R; Todd A
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneous, Simple, and Direct Analysis of Exosomal PD-L1 via Aptamer-Bivalent-Cholesterol-Anchor Assembly of DNAzyme (ABCzyme) for Tumor Immunotherapy.
    Hao J; Wang J; Dong Y; Yang J; Wang Z; Zhao X; Zeng T; Zhao X; Liang H; Li J
    Anal Chem; 2023 May; 95(17):6854-6862. PubMed ID: 37027485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression status of PD-L1 and B7-H3 in mesothelioma.
    Matsumura E; Kajino K; Abe M; Ohtsuji N; Saeki H; Hlaing MT; Hino O
    Pathol Int; 2020 Dec; 70(12):999-1008. PubMed ID: 33027549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of cancerous exosomal miRNA-21 and PD-L1 with a sensitive dual-cycling nanoprobe.
    Qin X; Xiang Y; Li N; Wei B; Chen Y; Fang D; Fang M; Li Q; Liu J; Tang Y; Li X; Yang F
    Biosens Bioelectron; 2022 Nov; 216():114636. PubMed ID: 35986985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
    Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
    Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-color fluorescence co-localization of PD-L1-overexpressing cancer exosomes.
    Wei J; Zhu K; Chen Z; Yang Z; Yang K; Wang Z; Zong S; Cui Y
    Mikrochim Acta; 2022 Apr; 189(5):182. PubMed ID: 35394232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
    Hsu PC; Miao J; Wang YC; Zhang WQ; Yang YL; Wang CW; Yang CT; Huang Z; You J; Xu Z; Jablons DM; You L
    J Cell Mol Med; 2018 Jun; 22(6):3139-3148. PubMed ID: 29575535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
    Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
    Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Throughput and Noninvasive Exosomal PD-L1 Detection for Accurate Immunotherapy Response Prediction via Tim4-Functionalized Magnetic Core-Shell Metal-Organic Frameworks.
    Wang H; Liu Y; Zhang L; Li X; Zhao G; Song Z; Jia Y; Qiao X
    Anal Chem; 2023 Dec; 95(49):18268-18277. PubMed ID: 38011622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
    Kao SC; Cheng YY; Williams M; Kirschner MB; Madore J; Lum T; Sarun KH; Linton A; McCaughan B; Klebe S; van Zandwijk N; Scolyer RA; Boyer MJ; Cooper WA; Reid G
    J Thorac Oncol; 2017 Sep; 12(9):1421-1433. PubMed ID: 28629895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of circulating exosomes and identification of exosomal PD-L1 for predicting immunotherapy response.
    Zhang J; Zhu Y; Guan M; Liu Y; Lv M; Zhang C; Zhang H; Zhang Z
    Nanoscale; 2022 Jun; 14(25):8995-9003. PubMed ID: 35700522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer.
    Liu B; Cao W; Qiao G; Yao S; Pan S; Wang L; Yue C; Ma L; Liu Y; Cui D
    Acta Biomater; 2019 Nov; 99():307-319. PubMed ID: 31513911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
    Ayala-Mar S; Donoso-Quezada J; González-Valdez J
    J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoplasmonic Sandwich Immunoassay for Tumor-Derived Exosome Detection and Exosomal PD-L1 Profiling.
    Wang C; Huang CH; Gao Z; Shen J; He J; MacLachlan A; Ma C; Chang Y; Yang W; Cai Y; Lou Y; Dai S; Chen W; Li F; Chen P
    ACS Sens; 2021 Sep; 6(9):3308-3319. PubMed ID: 34494426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Mesothelioma Effusions Are Infiltrated by CD3
    Khanna S; Thomas A; Abate-Daga D; Zhang J; Morrow B; Steinberg SM; Orlandi A; Ferroni P; Schlom J; Guadagni F; Hassan R
    J Thorac Oncol; 2016 Nov; 11(11):1993-2005. PubMed ID: 27544053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1.
    Yin Z; Yu M; Ma T; Zhang C; Huang S; Karimzadeh MR; Momtazi-Borojeni AA; Chen S
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.
    Bensaid D; Blondy T; Deshayes S; Dehame V; Bertrand P; Grégoire M; Errami M; Blanquart C
    Clin Epigenetics; 2018; 10():79. PubMed ID: 29946373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.